Rocky mountain spotted fever in the United States, 1997-2002

Vector-Borne and Zoonotic Diseases

Volumn 6, Issue 2, 2006, Pages 170-178

  Chapman, Alice S ^a   Murphy, Staci M ^a   Demma, Linda J ^a   Holman, Robert C ^a   Curns, Aaron T ^a   McQuiston, Jennifer H ^a   Krebs, John W ^a   Swerdlow, David L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Rickettsia; Spotted fever; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; FATALITY; FEMALE; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; ROCKY MOUNTAIN SPOTTED FEVER; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ROCKY MOUNTAIN SPOTTED FEVER; UNITED STATES;

ACARI;

EID: 33746153706     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2006.6.170     Document Type: Article

References (24)

1. AAP (American Academy of Pediatrics), Committee on Infectious Diseases. American Academy of Pediatrics. Rocky Mountain spotted fever. In: Pickering, LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases, 24th ed. Elk Grove Village, IL: AAP; 2000:491-493.
2. AAP (American Academy of Pediatrics), Committee on Infectious Diseases. Rocky Mountain spotted fever. In: Pickering, LK, ed. 2003 Red Book: Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: AAP; 2003:532-534.
3. Abramson, JS, Givner, LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics 1990; 86:123-124.
4. CDC (Centers for Disease Control and Prevention). National Electronic Telecommunications System for Surveillance - United States, 1990-1991. Morb Mortal Wkly Rep MMWR 1991; 40:502-503.
5. CDC (Centers for Disease Control and Prevention). Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997; 46:1-55.
6. CDC (Centers for Disease Control and Prevention). Consequences of delayed diagnosis of Rocky Mountain spotted fever in children - West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. Morb Mortal Wkly Rep 2000; 49:885-888.
7. CDC (Centers for Disease Control and Prevention). Fatal cases of Rocky Mountain spotted fever in family clusters -three states, 2003. MMWR Morb Mortal Wkly Rep 2003; 53:407-410.
8. Childs, JE, Paddock, CD. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 2002; 66:450-457.
9. Dalton, MJ, Clarke, MJ, Holman, RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995; 52:405-413.
10. Demma, LJ, Holman, RC, McQuiston, JH, et al. Epidemiology of human ehrlichiosis and anaplasmosis in the United States. Am J Trop Med Hyg 2005; 73:400-409.
11. Helmick, CG, Bernard, KW, D'Angelo, LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984; 150:480-488.
12. Holman, RC, Paddock, CD, Curns, AT, et al. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184:1437-1444.
13. Lochary, ME, Lockhart, PB, Williams, WT. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998; 17:1429-1431.
14. Masters, EJ, Olson, GS, Weiner, SJ, et al. Rocky Mountain spotted fever: a clinician's dilemma. Arch Intern Med 2003; 163:769-774.
15. O'Reilly, M, Paddock, C, Elchos, B, et al. Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever. Ann NY Acad Sci 2003; 990: 295-301.
16. Paddock, CD, Holman, RC, Krebs, JW, et al. Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg 2002; 67:349-354.
17. Purvis, JJ, Edwards, MS. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J 2000; 19:871-874.
18. Thorner, AR, Walker, DH, Petri, WA. Rocky Mountain spotted fever. Clin Infect Dis 1998; 27:1353-1360.
19. Treadwell, TA, Holman, RC, Clarke, MJ, et al. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 2000; 6:21-26.
20. Stallings, SP. Rocky Mountain spotted fever and pregnancy: a case report and review of the literature. Obstet Gynecol Surv 2001; 56:37-42.
21. U.S. Census Bureau. State population estimates and demographic components of population change: 1990 to 1999 [On-line]. Available at: , 2004a.
22. U.S. Census Bureau. Monthly postcensal resident population by single year of age, sex, race and Hispanic origin, 1990-2000, selected months [On-line]. Available at: , 2004b.
23. U.S. Census Bureau. National population estimates for the United States, April 1, 2000 to July 1, 2002 [On-line]. Available at: , 2004.
24. U.S. Census Bureau. Annual population estimates for the United States, by age and sex: April 1, 2000 to July 1, 2002 [On-line]. Available at: , 2004.